Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck

Rocco M. Ferrandino, Scott Roof, Jonathan Garneau, Yarah Haidar, Susan E. Bates, Yeun Hee A. Park, Joshua M. Bauml, Eric M. Genden, Brett Miles, Keith Sigel

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Background: Neutrophil-to-lymphocyte ratio (NLR) is a biomarker that is correlated with systemic inflammation and poor prognosis in solid tumors. We investigated the value of NLR in predicting survival in a large population of head and neck cancer patients in the United States. Methods: We performed a retrospective cohort study of Veterans Affairs patients with head and neck squamous cell carcinoma (HNSCC) diagnosed between January 2000 and December 2017. We compared 5-year overall survival and cancer-specific survival for different NLR tertiles using cox proportional hazards modeling with adjustment for covariates. Results: The primary cohort consisted of 14 644 subjects of which 99% were male. Relative to patients with NLRs in the lower tertile, patients with NLRs in the top tertile had an 71% increased hazard of all-cause mortality (P <.001) and 44% increased hazard of cancer-specific mortality (P <.001) at 5 years. Conclusions: Elevated NLR in HNSCC confers a poor prognosis.

Original languageEnglish
Pages (from-to)2830-2840
Number of pages11
JournalHead and Neck
Volume42
Issue number10
DOIs
StatePublished - 1 Oct 2020

Keywords

  • head and neck squamous cell carcinoma
  • laryngeal carcinoma
  • neutrophil-to-lymphocyte ratio
  • oral cavity carcinoma
  • oropharyngeal carcinoma

Fingerprint

Dive into the research topics of 'Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Cite this